SEOUL ADEX
Digital Directory
Filters Clear all
Clear all
Filters
Filters
Search
Country
Pavilions
Show results

Boeing advertising for Seoul ADEX Digital Directory

 

Boeing Advertising for Seoul ADEX digital directory

Featured Companies
Platform partners appearing at events across the globe
SynQor
Booth : E314
SynQor
Boxborough, Massachusetts, United States

Boeing advertising for Seoul ADEX digital directory

Airbus
Booth : C301
Airbus
France
Arizona Commerce Authority
Booth : D307
Arizona Commerce Authority
Phoenix, Arizona, United States
PBS
Booth : E553
PBS
Velka Bites, Velka Bites, Czech Republic
FlightGlobal
Booth : F143
FlightGlobal
Sutton, United Kingdom
Air Services International
Air Services International
Phoenix, Arizona, United States
Products & Services
Booth: D199
Lockheed Martin Product Information
Lockheed Martin Corporation
Current list of Lockheed Martin products.
Booth: F173
Asian Defence Journal
Asian Defence Journal (ADJ)
Asian Defence Journal (ADJ) is among the world’s leading international magazines specialising in defence and security matters. Its wide readership, comprising the top echelon of military and political decision-makers from the Asia-Pacific, has confirmed ADJ as the premier defence periodical in the region. It was among the first internationally audited defence publication in the region. Founded in 1969 and published monthly since 1970, the magazine covers political and security issues, defence technology, international defence programmes, industrial and economic matters. The journal’s focus includes interviews with ministers, top brass and senior executives of the defence industries.
Booth: D161
EchoFlight
Echodyne
EchoFlight is an airborne variant of the EchoGuard line. As drones become an ever-greater threat to warfighters and assets, novel methods for Counter-UAS are required. EchoFlight is designed for use on airborne platforms and is customizable to mission requirements. For temporary missions, EchoFlight’s Field of View (FoV) can be reduced for interceptor applications or kept broad for airspace surveillance. In either case, a low signals footprint on a mobile platform confuses enemy counter-fire and maintains situational awareness.
Booth: F144
Motion Reference Units (MRU) and Wave Sensors (WS)
Inertial Labs Inc.
The MRU is a high-performance strap-down Motion Sensor that determines Pitch & Roll, Heave, Surge, Sway, Linear acceleration, Angular Rates, Heading, Velocity, and Position for any device on which it is mounted to. The Inertial Labs team of skilled engineers provides expertise to help users select and configure from the models available: MRU-B1, MRU-B1.1, MRU-B2, MRU-E, MRU-P and MRU-PD (with subsea models available). Our support team helps set up units for all application bases to satisfy GNSS-enabled and GNSS-denied environments.
Booth: F144
LiDAR Remote Sensing Payload Instrument (RESEPI™)
Inertial Labs Inc.
The processing platform contains a WiFi interface, an embedded cellular modem to support RTCM corrections, data logging software, and gigabit ethernet. RESEPI™ can be used with commercially available LiDARs like Velodyne, Quanergy, Ouster, RIEGL, and LIVOX. The device was built with the purpose of white labeling. RESEPI is entirely modular. You can supply the GNSS receiver. You can supply the LiDAR. We provide everything for assembling, calibrating, and bore-sighting RESEPI™. This allows you to maintain existing relationships and meet local production requirements.
Booth: F144
Railway Motion Control Unit (RMCU)
Inertial Labs Inc.
The Inertial Labs RMCU utilizes three 3-axes, each precision MEMS accelerometer, miniature Fluxgate magnetometers, and MEMS gyroscopes, to provide accurate heading, pitch, and roll of the device under the measure. The integration of gyroscopes’ output provides high-frequency, real-time measurement of the device rotation for all three rotational axes. Accelerometers and Fluxgate magnetometers measure absolute and very accurately in static and dynamic conditions, such as pitch, roll, and heading/Azimuth at RMCU initial alignment, and provide ongoing corrections to gyroscopes during operation.
Booth: F144
Three Axis Accelerometers (TAA)
Inertial Labs Inc.
The TAA-308, TAA-315 and TAA-340 are revolutionary, compact, self-contained, strapdown, Navigation-grade Accelerometers that measure linear accelerations with high precision due to their unique design and developed by Inertial Labs over last 20 years several significant know-know and technics in calibrations of inertial sensors. Measured by TAA Accelerometers accelerations are determined with low noise and very good repeatability for both motionless and dynamic applications.
People
News
The CEO Magazine Interview with NephroCan CEO, Delaram Hajipour
As a busy executive in the health space, Delaram Hajipour might not have as much time as she would like to dedicate to her side passion: improvisational theater. But thankfully, the qualities that come so naturally on the stage are proving quite handy in the office as well. “Skills such as agility and teamwork translate into everyday work, so being an improviser definitely helps,” Hajipour tells The CEO Magazine. The one place where she doesn’t ad lib, however, is the business itself. In 2016, Hajipour established NephroCan to provide products and services in hemodialysis, or kidney replacement therapy. “We founded NephroCan on the belief that every hemodialysis patient deserves to have the best therapy built around their specific needs and that treatment should be accessible and affordable, irrespective of where they’re located or their circumstances,” she says. “Our vision is to innovate and improve technologies to help shift the paradigm of treatment for patients globally, and to provide products and services of genuine value.” A DIFFERENT VIEW Careers in health care run in the Hajipour family, who she says moved from Tehran, Iran to Vancouver, Canada when she was eight. Both her parents are doctors and from a very young age she knew that her future lay in the medical field. The exact destination, however, changed when she got bitten by the entrepreneurial bug. “I was on a very dedicated path to becoming a doctor as well,” she explains. “Then I realized that maybe there was a different way to tackle some of the challenges that patients go through – from a business angle.” nd, after seeing friends and family undergo rigorous hemodialysis treatment, often involving multiple hospital visits every week, the seed of the idea for NephroCan was planted. “In high school, I had a shoe painting business and in university, I sold an IP to an international company so I had my experiences. I had my fun,” she says. “Now, my focus is driving change in an industry that perhaps sees change a little bit slower than others.” THE SILENT DISEASE It may be what she describes as a “niche industry”, but as an illness, chronic kidney disease is the exact opposite. Around the globe, one-in-10 people are sufferers. “It’s known as the silent disease because it’s not something you show symptoms for, but it kills more people than breast cancer and prostate cancer,” she says. For patients in the final stage of the disease, hemodialysis is the most common kidney replacement therapy. As a fully integrated product and services company, NephroCan both manufactures and distributes proprietary products and acts as a consultant to others in the industry, from equipment manufacturers to healthcare providers. As well as its office headquarters in Vancouver, the company has invested heavily to create a footprint in Europe. Hajipour splits much of her time between North America, Germany and Türkiye, where NephroCan has manufacturing facilities, and Italy, where it has an office for CE (Conformité Européenne) representation and business development. With recent statistics from the International Society of Nephrology revealing that the median prevalence of chronic kidney disease is more than 35 percent in Europe, the Middle East and Africa, the region is of particular focus. “There is a lot of work that still needs to be done, and we believe NephroCan can make a positive impact to support the needs of patients in these regions,” she says. A FRESH PERSPECTIVE A young woman of color, Hajipour knows she doesn’t look like the typical CEO of a medical company, but she also appreciates how that plays to her advantage. “I come in with a fresh perspective and tackle challenges from different angles,” she says. One such challenge is the industry’s lag in home dialysis use, something NephroCan is set to change with home solutions, which are expected to be revealed in the next two-to-three years. “Home hemodialysis has many benefits,” she explains. “First and foremost, for the patient, it provides a better quality of life given the greater flexibility, increased independence and reduced travel time.” For healthcare providers, she continues, it allows for customized and tailored treatment plans to suit individual patient needs, a flexibility that improves patient outcomes. And, for governments, home hemodialysis supports budget and resource management – in developed countries, approximately three percent of healthcare budgets are spent on kidney failure treatment. Thanks to its vertical and horizontal integration, NephroCan is in a unique position to contribute home solutions. “Everything we do is in-house, from conception to execution,” she says. COLLABORATIVE CULTURE Hajipour predicts that home dialysis will be a huge driver over the next five years and hopes that others in the industry will join NephroCan as it takes the first steps in that direction. “Because the renal industry is small, it allows for cross-collaboration in a way that perhaps isn’t possible in other medical disciplines,” she reflects, affirming her belief that the future of care should be rooted in partnerships and innovation via a patient-first philosophy. Market research shows that the global kidney dialysis market is projected to reach US$156.8 billion in 2032, largely due to the rise in funding for the development of new products and the increase in the number of end-stage renal disease patients. “Now, more than ever, is a great time for key opinion leaders, nephrologists, non-profit organizations, governments and companies to come together,” Hajipour says. “At NephroCan, we call this the ‘win–win–win’ approach: empower healthcare providers, support governmental bodies responsible for funding and endorse nephrologists, while helping develop offerings that are in the best interest of patient wellbeing.” These might seem like lofty goals, but Hajipour’s passion is clear, and it all comes back to empathy for the patient. “People don’t know the gravity of this disease until they’re implicated with it,” she explains. “I want hemodialysis to be equal, accessible and affordable.”
21 Nov · NephroCan
NASA Looks Beyond X-66 Toward Future Generation Of Net-Zero Airliners
21 Nov · Aviation Week Network
Odys Makes First Transitions With Subscale eVTOL Drone
21 Nov · Aviation Week Network
Why Taiwanese SpaceX Suppliers Are Tailing Client To Southeast Asia
20 Nov · Aviation Week Network
Airbus A380 Provides Learning Platform For Composite Recycling
20 Nov · Aviation Week Network
Roswell Park Clinical Trial Points Toward Promising New Therapy for Most Aggressive Type of Breast Cancer
HIGHLIGHTS: - Triple-negative breast cancer accounts for 10-20% of all breast cancers - Study assessed a new pre-surgery immunotherapy/chemotherapy combination - Findings appear in Journal for ImmunoTherapy of Cancer
20 Nov · Roswell Park Comprehensive Cancer Center
Roswell Park Experts to Showcase Groundbreaking Hematology Research at 66th ASH Annual Meeting
HIGHLIGHTS: - Teams share new treatments for pediatric and adult lymphoma, leukemia, myeloma - Topics range from exercise interventions to new CAR T and cell therapies - Conference happening in San Diego December 7-10, 2024
20 Nov · Roswell Park Comprehensive Cancer Center
We use cookies

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.